Aparajita Lath Immunization Intellectual Property Pharmaceuticals Public Health Student Fellows Vaccines
patents
-
-
Visualizing the Growing Intersection of Life Sciences and Computing Patents in the US from 1976-2021
Read more: Visualizing the Growing Intersection of Life Sciences and Computing Patents in the US from 1976-2021 -
Aparajita Lath Immunization Intellectual Property Pharmaceuticals Public Health Student Fellows VaccinesCOVID-19 Vaccine Patent Infringement? The Battle Between Moderna and Pfizer/BioNTech Continues
Read more: COVID-19 Vaccine Patent Infringement? The Battle Between Moderna and Pfizer/BioNTech Continues -
Aparajita Lath Featured Global Health Health Law Policy Intellectual Property Pharmaceuticals Student Fellows VaccinesThe Secret World of mRNA: HDT Bio Corp v. Emcure and Access to Next-Gen mRNA
Read more: The Secret World of mRNA: HDT Bio Corp v. Emcure and Access to Next-Gen mRNA -
Biotechnology Featured Health Law Policy Intellectual Property Jorge Contreras Public Health VaccinesNo Take-Backs: Moderna’s Attempt to Renege on its Vaccine Patent Pledge
Read more: No Take-Backs: Moderna’s Attempt to Renege on its Vaccine Patent Pledge -
Aaron S. Kesselheim Ameet Sarpatwari Empirical FDA Generic Drugs Insurance Intellectual Property International Medicare/Medicaid Pharmaceuticals PORTAL Round-UpMonthly Round-Up of What to Read on Pharma Law and Policy
Read more: Monthly Round-Up of What to Read on Pharma Law and Policy -
Graduate Students’ Curricula Should Include Intellectual Property
Read more: Graduate Students’ Curricula Should Include Intellectual Property -
The Risk of Pervasive Trade Secret Practices Within the Life Sciences
Read more: The Risk of Pervasive Trade Secret Practices Within the Life Sciences -
Biotechnology Featured Genetics Health Information Technology History Intellectual Property Jorge Contreras Research Funding Scientific Evidence Supreme Court VaccinesWill NIH Learn from Myriad when Settling Its mRNA Inventorship Dispute with Moderna?
Read more: Will NIH Learn from Myriad when Settling Its mRNA Inventorship Dispute with Moderna? -
In Academia, Innovators Receive Unfair Compensation for Their Discoveries
Read more: In Academia, Innovators Receive Unfair Compensation for Their Discoveries